Literature DB >> 7513060

Endonuclease VII of phage T4 nicks N-2-acetylaminofluorene-induced DNA structures in vitro.

E Bertrand-Burggraf1, B Kemper, R P Fuchs.   

Abstract

We have tested in vitro the activity of T4 endonuclease VII on three different double-stranded oligonucleotides bearing a single N-2-acetylaminofluorene (AAF) adduct covalently bound to each of the three guanine residues located within the NarI site (G1G2CG3CC), a strong frameshift mutation hot spot in E. coli. With the oligonucleotides modified at G2 and G3 a specific cleavage pattern with T4 endonuclease VII was observed in the complementary strand while no cleavage was found in the adduct-bearing strand. On the other hand, when G1 was modified, only a very faint cleavage band was observed (< 1%). These differences in nicking among the three AAF-modified DNA substrates are discussed in terms of the polymorphic nature in adduct-induced DNA structures as previously shown. This "non-physiological" activity of a DNA resolvase is discussed in terms of a potential role for such enzymes in the induction of frameshift mutations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513060     DOI: 10.1016/0921-8777(94)90072-8

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  3 in total

1.  The RuvC protein dimer resolves Holliday junctions by a dual incision mechanism that involves base-specific contacts.

Authors:  R Shah; R Cosstick; S C West
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 2.  Bacteriophage T4 genome.

Authors:  Eric S Miller; Elizabeth Kutter; Gisela Mosig; Fumio Arisaka; Takashi Kunisawa; Wolfgang Rüger
Journal:  Microbiol Mol Biol Rev       Date:  2003-03       Impact factor: 11.056

3.  Human and E.coli excinucleases are affected differently by the sequence context of acetylaminofluorene-guanine adduct.

Authors:  D Mu; E Bertrand-Burggraf; J C Huang; R P Fuchs; A Sancar; B P Fuchs
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.